Overview
Also known as:
FDA & Trial Timeline
10 eventsWake Forest University Health Sciences
Quercis Pharma AG — PHASE3
IRCCS San Raffaele
Sahlgrenska University Hospital — NA
BioNTech SE — PHASE1, PHASE2
Imperial College London — NA
BioNTech SE — PHASE1, PHASE2
Peking University First Hospital — EARLY_PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableLynparza
for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, …
for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting
Clinical Trials
View all trials with filters →No actively recruiting trials found for Malignant vascular tumor at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersChildren's Hospital of Orange County
📍 Orange, California
👤 Richard Neibeger, MD
University of Alabama at Birmingham Cancer Center
📍 Birmingham, Alabama
Cedars Sinai Medical Center
📍 Los Angeles, California
👤 Janssen Research & Development, LLC Clinical Trial
Kingman Regional Medical Center
📍 Kingman, Arizona
Northwestern University
📍 Chicago, Illinois
👤 Ann (Annie) W Silk
PCR Oncology
📍 Arroyo Grande, California
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
📍 Jonesboro, Arkansas
University of South Alabama Mitchell Cancer Institute
📍 Mobile, Alabama
Financial Resources
2 resourcesProleukin
Chiron Corporation
Proleukin — Contact Chiron Corporation
Travel Grants
No travel grants are currently matched to Malignant vascular tumor.
Community
No community posts yet. Be the first to share your experience with Malignant vascular tumor.
Start the conversation →Latest news about Malignant vascular tumor
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Malignant vascular tumor
Which specialists treat Malignant vascular tumor?
25 specialists and care centers treating Malignant vascular tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Malignant vascular tumor?
1 patient support program are currently tracked on UniteRare for Malignant vascular tumor. See the treatments and support programs sections for copay assistance, eligibility, and contact details.